You are here

racketeering

Lilly, Takeda Face Class-Action Racketeering Lawsuit Over Diabetes Drug

BioSpace

Thu, 06/8/23 - 10:13 am

Sanofi, Lilly, Novo and a trio of PBMs face racketeering claims over pricey insulin drugs

Fierce Pharma

Tue, 07/13/21 - 11:32 pm

Express Scripts

Here’s how Insys schemed to deceive insurance companies

Boston Globe, MA

Mon, 02/25/19 - 11:36 pm

INSYS Therapeutics

Sales Team Rap Video Adds to John Kapoor's Woes at Opiod Trial

Bloomberg

Thu, 02/14/19 - 11:32 am

INSYS Therapeutics

Valeant faces racketeering accusations

BioPharma Dive

Thu, 09/1/16 - 09:22 am

Valeant Pharmaceuticals